drugset / Trial / NCT04649697
Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this intervention study is to compare the effect of topical Rebamipide (regular and nanoparticulated) to topical Clobetasol propionate in management of Methotrexate induced oral mucositis in patients with rheumatoid arthritis.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rebamipide | Small molecule | — | — |
| Comparator | clobetasol propionate | Small molecule | — | — |